Ropinirole alters gene expression profiles in SH-SY5Y cells: a whole genome microarray study

AUTOR(ES)

Zhu, M.Z., Le, W.D., Jin, G.

FONTE

Braz J Med Biol Res

DATA DE PUBLICAÇÃO

19/01/2016

RESUMO

Ropinirole (ROP) is a dopamine agonist that has been used as therapy for Parkinson's disease. In the present study, we aimed to detect whether gene expression was modulated by ROP in SH-SY5Y cells. SH-SY5Y cell lines were treated with 10 µM ROP for 2 h, after which total RNA was extracted for whole genome analysis. Gene expression profiling revealed that 113 genes were differentially expressed after ROP treatment compared with control cells. Further pathway analysis revealed modulation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway, with prominent upregulation of PIK3C2B. Moreover, batches of regulated genes, including PIK3C2B, were found to be located on chromosome 1. These findings were validated by quantitative RT-PCR and Western blot analysis. Our study, therefore, revealed that ROP altered gene expression in SH-SY5Y cells, and future investigation of PIK3C2B and other loci on chromosome 1 may provide long-term implications for identifying novel target genes of Parkinson's disease.

Documentos Relacionados

• Downregulation of survivin by siRNA inhibits invasion and promotes apoptosis in neuroblastoma SH-SY5Y cells
• Differential Modulation of μ- and δ-Opioid Receptor Agonists by Endogenous RGS4 Protein in SH-SY5Y Cells*
• Efeitos da alfa-sinucleína na modulação da atividade do fator de transcrição nuclear kB em células SH-SY5Y.
• Avaliação dos efeitos neuroprotetores da tianeptina e seu derivado NANT 03 em uma linhagem de células SH-SY5Y diferenciadas
• Modulation of basal nitric oxide-dependent cyclic-GMP production by ambient glucose, myo-inositol, and protein kinase C in SH-SY5Y human neuroblastoma cells.